Form 8-K - Current report:
SEC Accession No. 0001193125-21-003750
Filing Date
2021-01-07
Accepted
2021-01-07 08:00:54
Documents
16
Period of Report
2020-12-31
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d27027d8k.htm   iXBRL 8-K 26866
2 EX-10.1 d27027dex101.htm EX-10.1 25931
3 EX-10.2 d27027dex102.htm EX-10.2 90012
7 GRAPHIC g27027g0106223143874.jpg GRAPHIC 3452
8 GRAPHIC g27027g0106224044986.jpg GRAPHIC 3897
  Complete submission text file 0001193125-21-003750.txt   306709

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eldn-20201231.xsd EX-101.SCH 3092
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eldn-20201231_lab.xml EX-101.LAB 18137
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eldn-20201231_pre.xml EX-101.PRE 11422
9 EXTRACTED XBRL INSTANCE DOCUMENT d27027d8k_htm.xml XML 3402
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 21513015
SIC: 2834 Pharmaceutical Preparations